Target Name: LDLRAD2
NCBI ID: G401944
Other Name(s): low density lipoprotein receptor class A domain containing 2 | Low-density lipoprotein receptor class A domain-containing protein 2 | Low density lipoprotein receptor class A domain containing 2 | LRAD2_HUMAN | low density lipoprotein receptor A domain containing 2

Regulating LDL Cholesterol with LDLRAD2

Low density lipoprotein receptor class A domain containing 2 (LDLRAD2) is a protein that is expressed in various tissues throughout the body, including the liver, heart, and muscle. It is a member of the LDL receptor family, which is a protein that is involved in the uptake and processing of low density lipoprotein (LDL) cholesterol by the liver.

LDLRAD2 is unique among its kind in that it is a non-functional receptor, meaning that it does not have the ability to bind to LDL cholesterol. Instead, it is involved in the regulation of LDL cholesterol levels by the liver. Specifically, LDL cholesterol is either taken up into the liver for processing and removed, or it is released back into the bloodstream.

The LDL receptor family is a crucial component of the immune system, as it helps to keep cholesterol levels in check. Cholesterol is a fatty substance that is found in the blood, and it is an essential component of cell membranes and hormones. However, too much cholesterol in the blood can cause a number of health problems, including the development of heart disease and stroke.

LDLRAD2 is an important protein that helps to regulate the levels of LDL cholesterol in the body. It is part of a signaling pathway that helps to control the levels of LDL cholesterol in the liver. This signaling pathway involves the interaction between LDL cholesterol and LDL receptor class A domain containing 2.

LDLRAD2 is a protein that is made up of 254 amino acids. It has a calculated molecular mass of 31.1 kDa. LDL cholesterol is a major component of the blood, and it is found in the bloodstream as well as in the liver. LDL cholesterol is made by the liver using cholesterol esters, which are created from dietary cholesterol.

LDLRAD2 is involved in the regulation of LDL cholesterol levels by the liver. It is part of a signaling pathway that helps to control the levels of LDL cholesterol in the liver. This signaling pathway involves the interaction between LDL cholesterol and LDL receptor class A domain containing 2.

LDLRAD2 helps to regulate the levels of LDL cholesterol in the liver by controlling the activity of enzymes that are involved in the metabolism of LDL cholesterol. Enzymes are proteins that catalyze chemical reactions in the body, and they are essential for the growth and development of all living organisms.

LDLRAD2 is also involved in the regulation of LDL cholesterol levels by the liver by controlling the activity of enzymes that are involved in the metabolism of LDL cholesterol. Enzymes are proteins that catalyze chemical reactions in the body and they are essential for the growth and development of all living organisms.

LDLRAD2 is a non-functional receptor, meaning that it does not have the ability to bind to LDL cholesterol. Instead, it is involved in the regulation of LDL cholesterol levels by the liver. Specifically, LDL cholesterol is either taken up into the liver for processing and removed, or it is released back into the bloodstream.

LDLRAD2 is expressed in various tissues throughout the body, including the liver, heart, and muscle. It is a member of the LDL receptor family, which is a protein that is involved in the uptake and processing of low density lipoprotein (LDL) cholesterol by the liver.

In conclusion, LDLRAD2 is a non-functional receptor that is involved in the regulation of LDL cholesterol levels by the liver. It is a crucial component of the immune system and helps to keep cholesterol levels in check. By controlling the activity of enzymes that are involved in the metabolism of LDL cholesterol, LDLRAD2 helps to regulate the levels of LDL cholesterol in the liver and keep it under control. As a drug target or biomarker, LDLRAD2 has the potential to be used to treat

Protein Name: Low Density Lipoprotein Receptor Class A Domain Containing 2

More Common Targets

LDLRAD3 | LDLRAD4 | LDLRAP1 | LDOC1 | LEAP2 | LECT2 | LEF1 | LEF1-AS1 | LEFTY1 | LEFTY2 | LEKR1 | LELP1 | LEMD1 | LEMD1-AS1 | LEMD2 | LEMD3 | LENEP | LENG1 | LENG8 | LENG8-AS1 | LENG9 | LEO1 | LEP | LEPR | LEPROT | LEPROTL1 | LERFS | LETM1 | LETM2 | LETMD1 | LETR1 | Leukotriene B4 receptor (LTB4-R) | Leukotriene CysLT receptor | LEUTX | LEXM | LFNG | LGALS1 | LGALS12 | LGALS13 | LGALS14 | LGALS16 | LGALS17A | LGALS2 | LGALS3 | LGALS3BP | LGALS4 | LGALS7 | LGALS7B | LGALS8 | LGALS8-AS1 | LGALS9 | LGALS9B | LGALS9C | LGALSL | LGI1 | LGI2 | LGI3 | LGI4 | LGMN | LGMNP1 | LGR4 | LGR5 | LGR6 | LGSN | LHB | LHCGR | LHFPL1 | LHFPL2 | LHFPL3 | LHFPL3-AS1 | LHFPL3-AS2 | LHFPL4 | LHFPL5 | LHFPL6 | LHFPL7 | LHPP | LHX1 | LHX2 | LHX3 | LHX4 | LHX4-AS1 | LHX5 | LHX6 | LHX8 | LHX9 | LIAS | LIF | LIFR | LIFR-AS1 | LIG1 | LIG3 | LIG4 | LILRA1 | LILRA2 | LILRA3 | LILRA4 | LILRA5 | LILRA6 | LILRB1 | LILRB2